The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus

Clinical trial NCT04414579 · UNKNOWN

Trial details

NCT number: NCT04414579
Sponsor: Mountain Diabetes and Endocrine Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-03-27
Primary completion: 2021-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.